Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

350 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.
Fritsche HM, Burger M, Svatek RS, Jeldres C, Karakiewicz PI, Novara G, Skinner E, Denzinger S, Fradet Y, Isbarn H, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Tilki D, Otto W, Capitanio U, Izawa JI, Ficarra V, Lerner S, Sagalowsky AI, Schoenberg M, Kamat A, Dinney CP, Lotan Y, Shariat SF. Fritsche HM, et al. Among authors: fradet y. Eur Urol. 2010 Feb;57(2):300-9. doi: 10.1016/j.eururo.2009.09.024. Epub 2009 Sep 12. Eur Urol. 2010. PMID: 19766384
A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
Grossman HB, Gomella L, Fradet Y, Morales A, Presti J, Ritenour C, Nseyo U, Droller MJ; PC B302/01 Study Group. Grossman HB, et al. Among authors: fradet y. J Urol. 2007 Jul;178(1):62-7. doi: 10.1016/j.juro.2007.03.034. Epub 2007 May 11. J Urol. 2007. PMID: 17499283 Clinical Trial.
Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer.
Margulis V, Lotan Y, Karakiewicz PI, Fradet Y, Ashfaq R, Capitanio U, Montorsi F, Bastian PJ, Nielsen ME, Müller SC, Rigaud J, Heukamp LC, Netto G, Lerner SP, Sagalowsky AI, Shariat SF. Margulis V, et al. Among authors: fradet y. J Natl Cancer Inst. 2009 Jan 21;101(2):114-9. doi: 10.1093/jnci/djn451. Epub 2009 Jan 13. J Natl Cancer Inst. 2009. PMID: 19141773
p53 predictive value for pT1-2 N0 disease at radical cystectomy.
Shariat SF, Lotan Y, Karakiewicz PI, Ashfaq R, Isbarn H, Fradet Y, Bastian PJ, Nielsen ME, Capitanio U, Jeldres C, Montorsi F, Müller SC, Karam JA, Heukamp LC, Netto G, Lerner SP, Sagalowsky AI, Cote RJ. Shariat SF, et al. Among authors: fradet y. J Urol. 2009 Sep;182(3):907-13. doi: 10.1016/j.juro.2009.05.024. Epub 2009 Jul 17. J Urol. 2009. PMID: 19616250
p53 expression in patients with advanced urothelial cancer of the urinary bladder.
Shariat SF, Bolenz C, Karakiewicz PI, Fradet Y, Ashfaq R, Bastian PJ, Nielsen ME, Capitanio U, Jeldres C, Rigaud J, Müller SC, Lerner SP, Montorsi F, Sagalowsky AI, Cote RJ, Lotan Y. Shariat SF, et al. Among authors: fradet y. BJU Int. 2010 Feb;105(4):489-95. doi: 10.1111/j.1464-410X.2009.08742.x. Epub 2009 Jul 31. BJU Int. 2010. PMID: 19659466
350 results